Approvals/TGA/CSL Taiwan PRIVIGEN TW normal immunoglobulin (human) 5g (100g/L,10%) solution for intravenous infusion

Approved

STANDARD

CSL Taiwan PRIVIGEN TW normal immunoglobulin (human) 5g (100g/L,10%) solution for intravenous infusion

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: fc8a633019f25317
Product Name: CSL Taiwan PRIVIGEN TW normal immunoglobulin (human) 5g (100g/L,10%) solution for intravenous infusion
Artg Id: 444242
Artg Name: CSL Taiwan PRIVIGEN TW normal immunoglobulin (human) 5g (100g/L,10%) solution for intravenous infusion
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2024-03-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

fc8a633019f25317

Type

Standard